Show simple item record

dc.contributor.authorKhetarpal, Niyati
dc.contributor.authorPoddar, Ankur
dc.contributor.authorNemani, Satish K
dc.contributor.authorDhar, Nisha
dc.contributor.authorPatil, Aravind
dc.contributor.authorNegi, Priyanka
dc.contributor.authorPerween, Ashiya
dc.contributor.authorViswanathan, Ramaswamy
dc.contributor.authorLünsdorf, Heinrich
dc.contributor.authorTyagi, Poornima
dc.contributor.authorRaut, Rajendra
dc.contributor.authorArora, Upasana
dc.contributor.authorJain, Swatantra K
dc.contributor.authorRinas, Ursula
dc.contributor.authorSwaminathan, Sathyamangalam
dc.contributor.authorKhanna, Navin
dc.date.accessioned2013-07-26T14:14:02Z
dc.date.available2013-07-26T14:14:02Z
dc.date.issued2013
dc.identifier.citationDengue-specific subviral nanoparticles: design, creation and characterization. 2013, 11 (1):15 J Nanobiotechnologyen_GB
dc.identifier.issn1477-3155
dc.identifier.pmid23706089
dc.identifier.doi10.1186/1477-3155-11-15
dc.identifier.urihttp://hdl.handle.net/10033/297056
dc.description.abstractDengue is today the most significant of arboviral diseases. Novel tools are necessary to effectively address the problem of dengue. Virus-like particles (VLP) offer a versatile nanoscale platform for developing tools with potential biomedical applications. From the perspective of a potentially useful dengue-specific tool, the dengue virus envelope protein domain III (EDIII), endowed with serotype-specificity, host receptor recognition and the capacity to elicit virus-neutralizing antibodies, is an attractive candidate.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of nanobiotechnologyen_GB
dc.titleDengue-specific subviral nanoparticles: design, creation and characterization.en
dc.typeArticleen
dc.contributor.departmentRecombinant Gene Products Group, International Centre for Genetic Engineering & Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India. swami@icgeb.res.in.en_GB
dc.identifier.journalJournal of nanobiotechnologyen_GB
refterms.dateFOA2018-06-13T03:46:49Z
html.description.abstractDengue is today the most significant of arboviral diseases. Novel tools are necessary to effectively address the problem of dengue. Virus-like particles (VLP) offer a versatile nanoscale platform for developing tools with potential biomedical applications. From the perspective of a potentially useful dengue-specific tool, the dengue virus envelope protein domain III (EDIII), endowed with serotype-specificity, host receptor recognition and the capacity to elicit virus-neutralizing antibodies, is an attractive candidate.


Files in this item

Thumbnail
Name:
Khetarpal et al_final.pdf
Size:
1.004Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record